Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1

Hypoxia activates hypoxia-inducible factor 1, which promotes the progression of malignancy by stimulating angiogenesis and by augmenting the ability of tumors to survive. Thus, HIF-1 is one of the most compelling targets for treating cancers. The aim of this study was to find a small molecule that i...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yong-Joon, Shin, Hyun-Woo, Chun, Yang-Sook, Leutou, Alain Simplice, Son, Byeng Wha, Park, Jong-Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308714/
https://www.ncbi.nlm.nih.gov/pubmed/27613833
http://dx.doi.org/10.18632/oncotarget.11529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308714/
https://www.ncbi.nlm.nih.gov/pubmed/27613833
http://dx.doi.org/10.18632/oncotarget.11529

Ejemplares similares